Max India
Max India Performance
Day Range
- Low 141.50
- High 147.00
52 Week Range
- Low 76.00
- High 195.00
- Open Price147.00
- Previous Close146.25
- Volume71065
Start SIP in Max India
Start SIPMax India Investment Rating
-
Master Rating:
-
Max India has an operating revenue of Rs. 189.31 Cr. on a trailing 12-month basis. An annual revenue de-growth of -10% needs improvement, Pre-tax margin of -1% needs improvement, ROE of -1% is poor and needs improvement. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 17% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 1 which is a POOR score indicating inconsistency in earnings, a RS Rating of 64 which is FAIR indicating the recent price performance, Buyer Demand at C which is evident from recent supply seen, Group Rank of 65 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 8 | 8 | 8 | 8 | 8 | 8 | 9 |
| Operating Expenses Qtr Cr | 6 | 7 | 7 | 6 | 6 | 6 | 6 |
| Operating Profit Qtr Cr | 2 | 2 | 2 | 2 | 2 | 3 | 2 |
| Depreciation Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | -2 | 0 | 1 | 1 |
| Net Profit Qtr Cr | 1 | 1 | 1 | 8 | 1 | 2 | 2 |
Max India Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 6
- Bearish Moving Average
- ___
- 10
- 20 Day
- ₹144.75
- 50 Day
- ₹144.91
- 100 Day
- ₹141.17
- 200 Day
- ₹128.88
- 20 Day
- ₹145.21
- 50 Day
- ₹143.31
- 100 Day
- ₹150.64
- 200 Day
- ₹122.89
Max India Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 146.80 |
| Second Resistance | 149.65 |
| Third Resistance | 152.30 |
| RSI | 48.42 |
| MFI | 39.31 |
| MACD Single Line | 0.24 |
| MACD | 0.07 |
| Support | |
|---|---|
| First Resistance | 141.30 |
| Second Resistance | 138.65 |
| Third Resistance | 135.80 |
Max India Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 76,604 | 4,781,622 | 62.42 |
| Week | 52,476 | 3,434,521 | 65.45 |
| 1 Month | 58,245 | 3,578,582 | 61.44 |
| 6 Month | 216,217 | 9,385,985 | 43.41 |
Max India Result Highlights
Max India Synopsis
NSE-Medical-Hospitals
Max India belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 32.54 Cr. and Equity Capital is Rs. 43.03 Cr. for the Year ended 31/03/2023. Max India Ltd. is a Public Limited Listed company incorporated on 23/01/2019 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74999MH2019PLC320039 and registration number is 320039.| Market Cap | 621 |
| Sales | 32 |
| Shares in Float | 2.12 |
| No of funds | 15 |
| Yield |
| Book Value | 0.72 |
| U/D Vol ratio | 0.8 |
| LTDebt / Equity | |
| Alpha | 0.17 |
| Beta | 1.22 |
Max India
| Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
|---|---|---|---|---|
| Promoters | 50.94% | 51.11% | 51.11% | 51.11% |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 10.59% | 10.71% | 11.26% | 11.38% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 32.37% | 33.27% | 32.99% | 32.08% |
| Others | 6.1% | 4.91% | 4.64% | 5.43% |
Max India Management
| Name | Designation |
|---|---|
| Mr. Analjit Singh | Founder & Chairman |
| Ms. Tara Singh Vachani | Vice Chairperson |
| Mr. Rajit Mehta | Managing Director |
| Mr. Mohit Talwar | Non Executive Director |
| Mr. Pradeep Pant | Independent Director |
| Mr. Ashok Kacker | Independent Director |
| Ms. Sharmila Tagore | Independent Director |
| Ms. Bhawna Agarwal | Independent Director |
| Dr. Ajit Singh | Independent Director |
| Mr. Niten Malhan | Independent Director |
| Mr. Rohit Kapoor | Independent Director |
Max India Forecast
Price Estimates
Max India Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-10-26 | Quarterly Results | |
| 2023-08-11 | Quarterly Results | |
| 2023-05-25 | Audited Results | |
| 2023-02-02 | Quarterly Results | |
| 2022-08-04 | Quarterly Results |
Max India FAQs
What is Share Price of Max India ?
Max India share price is ₹143 As on 02 December, 2023 | 18:00
What is the Market Cap of Max India ?
The Market Cap of Max India is ₹621.4 Cr As on 02 December, 2023 | 18:00
What is the P/E ratio of Max India ?
The P/E ratio of Max India is -28.4 As on 02 December, 2023 | 18:00
What is the PB ratio of Max India ?
The PB ratio of Max India is 1.1 As on 02 December, 2023 | 18:00